We advised the WSE-listed company Creotech Instruments S.A.

16.10.2023 Case studies Capital Markets

We advised the WSE-listed company Creotech Instruments S.A.

We advised the WSE-listed company Creotech Instruments S.A. on a non-brokered public offering conducted under an accelerated bookbuilding procedure worth approximately PLN 60 million.

Creotech Instruments is a manufacturer of satellites, satellite systems and components and the first Polish space company listed on the WSE.

We advised Creotech Instruments on all legal aspects related to the transaction. The work of the team supervised by Krzysztof Marczuk (partner) was led by Michał Wieliński (managing associate). The transaction team consisted of Magdalena Szeplik (managing associate), Maciej Kowalski (senior associate), Dawid Marciniak (associate) and Michał Dunikowski (associate).

Thank you for your trust and fruitful cooperation. We congratulate Creotech Instruments and all those involved in the transaction.

Lawyers involved in the project

We advised the WSE-listed company Creotech Instruments S.A.

Krzysztof Marczuk

Partner
Attorney-at-law

Capital Markets

Krzysztof Marczuk
We advised the WSE-listed company Creotech Instruments S.A.

Michał Wieliński

Managing Associate
Attorney-at-law

Capital Markets | Mergers and acquisitions (M&A) | Corporate law

Michał Wieliński
We advised the WSE-listed company Creotech Instruments S.A.

Magdalena Marczuk

Counsel
Advocate

Capital Markets | Corporate law

Magdalena Marczuk

You may also like

09.09.2026

GESSEL advises DCX and its founders on LITEON’s USD 176 million strategic investment

GESSEL advised DCX Polska sp. z o.o. (“DCX Liquid Cooling Systems”), a manufacturer of advanced liquid cooling systems for data centres supporting artificial intelligenc...

Case studies
GESSEL advises DCX and its founders on LITEON’s USD 176 million strategic investment

08.09.2026

GESSEL advises LUX MED Group on the acquisition of Endomed

GESSEL advised LUX MED sp. z o.o., Poland’s leading private healthcare provider and part of the international Bupa group, on the acquisition of 100% of the shares in End...

Case studies
GESSEL advises LUX MED Group on the acquisition of Endomed
Wszystkie case studies

Do you want to be up to date?

Subscribe to the newsletter!

We advised the WSE-listed company Creotech Instruments S.A.